Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

NCT04286126 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04286126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04286126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2021
Completion date
December 15, 2025
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder